Motivating Structured Walking Activity in Intermittent Claudication

NCT03238222 — Not applicable, Unknown, 192 participants, Guy's and St Thomas' NHS Foundation Trust

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Brief Physiotherapist-led Behaviour Change Intervention to Facilitate Walking in Older People With Peripheral Arterial Disease: a Randomised Controlled Trial

RegistryNCT03238222, acronym MOSAIC
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment192 (Estimated)
SponsorGuy's and St Thomas' NHS Foundation Trust (Other); collaborators: King's College London, The Dunhill Medical Trust
ConditionsPeripheral Arterial Disease, Intermittent Claudication, Peripheral Vascular Disease
InterventionsMOSAIC (Behavioral)
Datesstart 2017-11-10, primary completion 2020-11-09 (estimated), completion 2021-01-09 (estimated), first posted 2017-08-03, last updated 2019-12-11
Locations9 sites in United Kingdom

Related Papers Related Patents Related Grants Related Experts
All trials for Peripheral Arterial Disease All trials for Intermittent Claudication All trials of MOSAIC

-Summary

Peripheral arterial disease can cause leg pain or discomfort (called intermittent claudication (IC)), which limits the ability to walk and carry out everyday activities. Lifestyle changes, like increasing walking, can lead to improvements, but can be a challenge to begin and then continue. The aim of this study is to investigate if a physiotherapist-led, behaviour change treatment effects walking in people with IC. The treatment is designed to build an understanding of IC and walking exercise and help individuals develop strategies to increase regular walking. The trial will recruit 192 adults (aged 50 years and over) with IC. All participants will visit King's College London or their local hospital to complete two short walking tests and answer questionnaires about their daily activities, beliefs about their symptoms and treatment, quality of life and the costs of having IC.

Participants will then be randomly assigned to receive either the new treatment or continue with their usual NHS care. The new treatment involves two 60-minute face-to-face sessions (at the participant's home or local hospital) and two 20-minute telephone calls with a physiotherapist who will discuss participants' understanding and beliefs about IC, walking and help participants to set goals and plans to increase walking over 12 weeks. Participants will be provided with a step counter (pedometer) and walking record.

After 12 weeks, all participants will attend a second appointment where they will repeat the walking tests and fill out another set of questionnaires. A final set of questionnaires will be completed by all participants after 6 months (by post or electronically). Some participants will be invited to provide feedback on their experience of the treatment and trial by telephone or a face-to-face interview with a researcher.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
MOSAIC TreatmentExperimentalBehavioral: MOSAICMOSAIC treatment plus Usual NHS Care. MOSAIC treatment comprises 2 x 60-minute individual face-to-face consultations (weeks 1 \& 2) and 2 x 20-minute follow-up telephone calls (weeks 6 \& 12) with a trained physiotherapist.
Usual Care ComparisonNo interventionUsual NHS care for people with intermittent claudication typically consists of an initial assessment, drug therapy and simple advice to walk provided by a vascular specialist and delivered in the vascular outpatient clinic.
  • MOSAIC (Behavioral), also known as Motivating Structured walking Activity in IC: MOSAIC comprises 2 x 60-minute individual face-to-face consultations (weeks 1 \& 2) and 2 x 20-minute follow-up telephone calls (weeks 6 \& 12) delivered at a convenient time and location of participant's choice (local NHS Trust or participant's home). All sessions are delivered by a trained Band 6/7 physiotherapist. All participants randomized to receive MOSAIC will be provided with a pedometer and a patient manual which will include information on intermittent claudication, risk factors, walking guidelines, goal setting, problem solving and action planning worksheets and a walking diary.

+Outcome measures

Primary outcomes

  • 6 Minute Walk Distance [3 months]: 6 Minute Walking Distance (in metres) measured during a self-paced, standardised 6 Minute Walk Test conducted around a level, 100-foot circuit.

Secondary outcomes

  • 6 Minute Walk Distance (6MWD) [Baseline and 3 months]: 6 Minute Walking Distance (in metres) measured during a self-paced, standardised 6 Minute Walk Test conducted around a level, 100-foot circuit.
  • Self-reported Maximum Walking Distance [Baseline, 3 and 6 months]: Single global item
  • Self-Reported Walking Ability [Baseline, 3 and 6 months]: Walking Estimated-Limitation Calculated by History (WELCH)
  • Activities of Daily Living [Baseline, 3 and 6 months]: Nottingham Extended Activities of Daily Living (NEADL)
  • Health-Related Quality of Life [Baseline, 3 and 6 months]: Vascular Quality of Life Questionnaire-6 (VascuQol-6)

Other outcomes

  • Treatment Cognitions [Baseline, 3 and 6 months]: Theory of Planned Behaviour Questionnaire
  • Illness Cognitions [Baseline, 3 and 6 months]: Brief Illness Perceptions Questionnaire (BIPQ)
  • Walking Adherence [Baseline, 3 and 6 months]: Exercise Adherence Rating Scale
  • Resource Use [Baseline, 3 and 6 months]: Client Service Receipt Inventory
  • Health Related Quality of Life [Baseline, 3 and 6 months]: Euroqol- 5D-5L
  • Pain Free Walking Ability [Baseline and 3 months]: Patient-reported pain free walking time (seconds) and distance (metres) during the 6 Minute Walk Test
  • Maximal Walking Ability [Baseline and 3 months]: The maximum time (seconds) and distance (metres) walked before stopping during a 6 Minute Walk Test

+Eligibility

Sex: All, ages: 50 Years to any

Inclusion Criteria:

* ≥50 years of age;
* established PAD (Ankle Brachial Pressure Index ≤0.90 and/or radiographic evidence or clinician reported diagnosis) and IC (presence of symptoms reported on the San Diego Claudication Questionnaire)
* able to participate in MOSAIC
* able and willing to provide informed consent

Exclusion Criteria:

* Unstable IC (self-reported change in symptoms during previous 3 months)
* walking >90 minutes/week (reported on Brief International Physical Activity Questionnaire
* contraindications to walking exercise (e.g., unstable angina) confirmed by their vascular specialist
* have completed any prescribed supervised exercise sessions in the previous 6 months or been offered prescribed exercise sessions in the next 6 months.

+Locations (9)

FacilityCityCountryStatus
Dartford and Gravesham NHS Trust (GSTT PIC site)Dartford, KentUnited KingdomRecruiting
Maidstone and Tunbridge Wells NHS Trust (GSTT PIC site)Maidstone, KentUnited KingdomRecruiting
Ashford & St Peter's NHS Foundation TrustAshford, SurreyUnited KingdomRecruiting
Guy's & St Thomas NHS Foundation TrustLondonUnited KingdomRecruiting
King's College Hospital NHS Foundation TrustLondonUnited KingdomRecruiting
Lewisham and Greenwich NHS Trust (GSTT PIC site)LondonUnited KingdomRecruiting
Royal Free London NHS Foundation TrustLondonUnited KingdomRecruiting
St George's University Hospital NHS Foundation TrustLondonUnited KingdomRecruiting
The Royal London Hospital, Barts Heatth NHS TrustLondonUnited KingdomRecruiting

+Publications

  • Results publication: Bearne LM, Volkmer B, Peacock J, Sekhon M, Fisher G, Galea Holmes MN, Douiri A, Amirova A, Farran D, Quirke-McFarlane S, Modarai B, Sackley C, Weinman J, Bieles J; MOSAIC Trial Collaboration. Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial. JAMA. 2022 Apr 12;327(14):1344-1355. doi: 10.1001/jama.2022.3391. PMID 35412564

+Investigators

  • Sanjay Patel, Principal investigator, Guy's and St Thomas' NHS Foundation Trust